32766463|t|Insights on cannabidiol's antiallodynic and anxiolytic mechanisms of action in a model of neuropathic pain.
32766463|a|Recent studies have shown that cannabidiol (CBD) could have a great therapeutic potential for treating disorders such as chronic pain and anxiety. In the target article, the authors propose that CBD modulates serotonergic transmission and reverses allodynia and anxiety-like behaviour in a rat model of neuropathic pain. Furthermore, this study shows an antinociceptive effect mediated by TRPV1 and partially by 5-HT1A receptors, as well as an anxiolytic effect mediated by 5-HT1A receptors. Commentary on: De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, and Gobbi G. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. PAIN 2019;160:36-150.
32766463	12	23	cannabidiol	Chemical	MESH:D002185
32766463	90	106	neuropathic pain	Disease	MESH:D009437
32766463	139	150	cannabidiol	Chemical	MESH:D002185
32766463	152	155	CBD	Chemical	MESH:D002185
32766463	229	241	chronic pain	Disease	MESH:D059350
32766463	246	253	anxiety	Disease	MESH:D001007
32766463	303	306	CBD	Chemical	MESH:D002185
32766463	356	365	allodynia	Disease	MESH:D006930
32766463	370	377	anxiety	Disease	MESH:D001007
32766463	398	401	rat	Species	10116
32766463	411	427	neuropathic pain	Disease	MESH:D009437
32766463	497	502	TRPV1	Gene	83810
32766463	734	745	Cannabidiol	Chemical	MESH:D002185
32766463	800	809	allodynia	Disease	MESH:D006930
32766463	814	821	anxiety	Disease	MESH:D001007
32766463	850	866	neuropathic pain	Disease	MESH:D009437
32766463	Negative_Correlation	MESH:D002185	MESH:D059350
32766463	Negative_Correlation	MESH:D002185	MESH:D006930
32766463	Negative_Correlation	MESH:D002185	MESH:D009437
32766463	Negative_Correlation	MESH:D002185	MESH:D001007

